Bexacat is a once-daily tablet alternative to insulin for treating feline diabetes. It lowers blood sugar by increasing urine excretion of glucose through inhibition of sodium-glucose …

Bexacat™ (bexagliflozin tablets) is the FIRST and ONLY single-dose chewable tablet for treating feline diabetes in otherwise healthy cats not previously treated with insulin.

Bexacat is the first and only needle-free, insulin-free, oral feline diabetes treatment for otherwise healthy cats not previously treated with insulin. If you think your cat may have diabetes, see …

2023年5月15日 · Brand Name: Bexacat. Available in 15 mg tablets . Background. Diabetes mellitus in cats is traditionally treated with insulin injections, glucose monitoring either at home …

2023年12月14日 · FDA has approved two new drugs to treat diabetes mellitus (high blood sugar) in cats. Both drugs are given orally (by mouth) once daily. Bexacat (bexagliflozin tablets) and …

Bexagliflozin, the active ingredient in Bexacat, prevents the cat’s kidneys from reabsorbing glucose into the blood, causing excess glucose to be passed out in the urine and resulting in …

Bexacat is used to lower the amount of glucose (sugar) in the blood of otherwise healthy cats with diabetes mellitus not previously treated with insulin. Bexacat causes sugar to be passed out in …

2023年10月17日 · Bexacat is an alternative to providing injections of insulin, a hormone. It is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not …

2024年4月3日 · Bexacat is the first oral diabetes treatment approved for cats in a new class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. An SGLT2 inhibitor is not …

2022年12月9日 · Bexacat is the first sodium-glucose cotransporter 2 (SGLT2) inhibitor approved by the FDA in any animal species. Bexacat introduces a new mechanism of action for …